ID: ALA4468363

Max Phase: Preclinical

Molecular Formula: C15H17ClN4O

Molecular Weight: 304.78

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(NC1CN2CCC1CC2)c1cc(Cl)cn2ccnc12

Standard InChI:  InChI=1S/C15H17ClN4O/c16-11-7-12(14-17-3-6-20(14)8-11)15(21)18-13-9-19-4-1-10(13)2-5-19/h3,6-8,10,13H,1-2,4-5,9H2,(H,18,21)

Standard InChI Key:  GJKKYLAFWKQEDD-UHFFFAOYSA-N

Associated Targets(Human)

Serotonin 3a (5-HT3a) receptor 3366 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 304.78Molecular Weight (Monoisotopic): 304.1091AlogP: 1.81#Rotatable Bonds: 2
Polar Surface Area: 49.64Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.48CX Basic pKa: 7.85CX LogP: 0.81CX LogD: 0.23
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.92Np Likeness Score: -1.22

References

1. Vanda D, Zajdel P, Soural M..  (2019)  Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases.,  181  [PMID:31404862] [10.1016/j.ejmech.2019.111569]

Source